News Alnylam plunges after deaths in rare disease trial Biotech axes revusiran due to safety concerns.
News Sandoz, Teva and Mylan generics to be suspended in EU Regulator concerned over data from contract research organisation.
News Patients may have quit statins after media row Coverage may have given "disproportional weight" to concerns over side effects.
News Victoza disappoints on cardio benefits, lifts rival Jardianc... Victoza results are significant, but fell short of investors' expectations.
News US pharma tariffs of up to 100% finalised by Trump Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
